Facilitate the production of a wide range of biologic modalities with our state-of-the-art facilities and expert capabilities.
Our development and manufacturing expertise spans a wide range of biologic modalities, including:
In addition to our broad range of modalities, we can also support you throughout your product development lifecycle with services such as comprehensive analytical testing.
We are a global CDMO and biosimilar developer dedicated to impacting the global healthcare landscape by bringing trusted and affordable medicines to market, quickly.
We understand that each modality has unique requirements, and we are committed to providing you with the highest quality products and services. Our flexible development and manufacturing platforms allow us to quickly and efficiently produce modalities, regardless of their complexity or scale.
Our proprietary continuous bioprocess manufacturing platform, EnzeneX™ further enhances production, with accelerated rates and a significant reduction in the cost of producing complex modalities — from mAbs to complex proteins.
A platform that pushes your project further.
Unlocking higher yields across a range of biologics at significantly lower costs to you, our patented continuous bioprocess manufacturing platform represents the pinnacle of our ongoing commitment to innovation.
EnzeneX™ harnesses the power of intensified perfusion using alternate tangential flow (ATF) and automated multi-column chromatography to achieve continuous production of biologics.
Designed for efficiency and cost-effectiveness, EnzeneX™ enables uninterrupted loading and processing of materials, delivering superior product quality and manufacturing outcomes.
Fueled by our continuous innovation and armed with EnzeneX™, our fully-integrated CDMO solutions and our biosimilars pipeline are designed to help bring your biologics innovations to life.